ArticleEuropean journal of medical research2025

Effectiveness and safety of orelabrutinib combined with rituximab, temozolomide, methotrexate, and cytarabine in intensive chemotherapy-unfit patients with PCNSL in China.

Zhigang Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.